Electronic patient monitoring system

Information

  • Patent Grant
  • 11776671
  • Patent Number
    11,776,671
  • Date Filed
    Friday, December 11, 2020
    3 years ago
  • Date Issued
    Tuesday, October 3, 2023
    7 months ago
  • CPC
    • G16H10/65
    • G16H10/60
    • G16H20/10
    • G16H40/67
    • G16H20/40
  • Field of Search
    • CPC
    • G16H10/65
    • G16H10/60
    • G16H20/10
    • G16H40/67
    • G16H20/40
  • International Classifications
    • G16H10/65
    • G16H20/10
    • G16H40/67
    • G16H10/60
    • G16H20/40
    • Disclaimer
      This patent is subject to a terminal disclaimer.
      Term Extension
      201
Abstract
An electronic patient monitoring system comprising a monitoring client and a remote communicator are provided. The monitoring client is configured to store patient information. The patient information may be patient-specific information. The monitoring client may receive the information from a database, e.g., through a monitoring server.
Description
BACKGROUND

The present invention relates to systems and methods to provide electronic intermediation among medical devices delivering treatments to patients, medical devices monitoring parameters associated with those patients, and health care providers who order, process or initiate those treatments. An object of the invention is to reduce the incidence of medical treatment errors, and to improve the efficiency of tracking a patient's course of treatment.


Despite the existence of systems incorporating electronic medical records (“EMR”), and computerized provider order entry (“CPOE”), the process of ordering and delivering medical treatments still has the potential to cause critical information to be miscommunicated, to allow treatment decisions to be made without ready access to complete information, and to delay implementation of treatment orders due to unnecessarily redundant and inefficient procedures. An approach to dealing with this problem is illustrated herein by using medication ordering as an example. It should be noted, however, that the invention as described herein can be applied to other treatment or diagnostic decisions involving the care of a patient.


Medication errors may be responsible for over 300 deaths and may injure over one million people each year in the United States. Hospitals under financial stress may experience an increased incidence of medication errors. Medications associated with the most dangerous errors include insulin, narcotics, heparin and chemotherapy. Sources of error include administering the wrong drug, the wrong concentration of drug, at the wrong rate, or via the wrong route (medications can be administered orally, intravenously, intramuscularly, subcutaneously, rectally, topically to the skin, eye or ear, intrathecally, intraperitoneally or even intravesically). Even with proper orders and proper labeling, medications still can be administered improperly because of illegible handwriting, miscommunication of orders, and mispronunciation of drugs having similar names. The trend toward the use of electronic medical records (EMR), and bar coding systems for medications has been shown to reduce the incidence of medication errors. EMR systems, for example, can facilitate computerized provider order entry (CPOE), and flag orders for drugs that do not match a patient's characteristics such as diagnosis, allergies, weight or age. However, these systems have not been widely adopted, and their implementation can result in significant delays and inefficiencies in ordering, preparing and administering medications.


It has been estimated that medication infusion devices are involved in up to one third of all medication errors that result in significant harm. The wrong drug may be hung, incorrect parameters (e.g. drug concentration or rate of infusion) may be entered, or existing infusion parameters may be improperly changed. Of infusion pump-related deaths, nearly half may be due to user error, and most of these may be due to errors in programming the infusion device.


An effective Monitoring system should monitor and intercede at any phase of the medication ordering and administration process to help minimize any of a number of adverse events that could result from the treatment. The medication treatment process conceptually can be separated into three phases: a prescription phase, a medication preparation phase, and an administration phase. Errors can occur when a prescription is written or entered, when a drug is retrieved for use or mixed in solution, or when it is administered to the patient. It would be particularly desirable for a monitoring system to not significantly impair the efficiency with which medications are ordered, prepared or administered, and preferably to actually reduce the time required to perform those activities by collecting, organizing and presenting relevant real-time information to the user.


SUMMARY

In an exemplary embodiment involving the ordering and administration of medications, the Electronic Patient Monitoring system may comprise a first data-gathering module (e.g., a Monitoring Client) and a second order-input module (e.g. a fixed or portable communications device) having a user interface for transmitting an order or receiving patient-related information. The first module may be configured to receive and store measured parameters pertaining to a patient's current condition, such as blood pressure, heart rate, heart rhythm, temperature, oxygenation, respiratory rate, or ventilation, for example. The first module may also be configured to receive information about pre-existing parameters related to the patient from a first database (e.g. an EHR database containing information about the patient), including drug allergies or sensitivities, other currently administered drugs, age, weight, height, kidney or liver function, for example. The first module may also be configured to obtain medication information about the ordered medication and/or pre-existing drugs from a second database (e.g. a drug information database), such as known drug interactions, effects of the medication or pre-existing drugs on blood pressure, pulse, heart rhythm, or respirations, for example. The first module can be configured to compare the patient's currently measured parameters and received pre-existing parameters with known normal ranges, and create a table of patient parameters found to be outside the normal ranges. The first module may then compare the table of patient parameters with a table of corresponding parameters obtained from the drug information database. If a match is found to exist between the table of patient parameters and the table of corresponding parameters, the first module may then retrieve one or more pre-entered and stored messages for transmission to the second (order input) module. These messages may include, for example, warnings to a user of the second module that are appropriate for the particular medication ordered, the patient's pre-existing drugs, and the patient's current and pre-existing medical condition. Optionally, further repetitions of warnings may be avoided once a warning has been received by the second module, and the warning has been acknowledged by the user of the second module through an input signal from the user interface.


In other embodiments, the Electronic Patient Monitoring system may provide the user with editable default values derived from standard dosing and administration guidelines obtained from the drug information database, and can alert the user to modifications that may be indicated based on the patient's current and pre-existing medical condition, allergies or other existing drugs. The Monitoring system preferably minimizes the amount of typed input required of a user.


In other embodiments, the first module or other modules of the Electronic Patient Monitoring system may also be used to identify ordered medications to be delivered to the patient's bedside (through the use of, for example, bar codes and readers or RFID tags and scanners), and verify that the appropriate medication and dosage are being prepared and delivered to the patient. In an embodiment, the first module may also interact either in a hard-wired or wireless fashion with a device that administers treatment, such as a solution/medication infusion pump. In the case of an infusion pump, the first module or another connected module may provide the pump with infusion settings such as flow rate or infusion pressure, and receive from it various state parameters such as, for example, the presence of air in the infusion line, the amount of solution remaining in an IV bag to which it is connected, or the pressure of fluid in the infusion line. If the parameters are found to be abnormal, the first module may be configured to respond by signaling the pump to halt infusion, alter the rate of infusion, and/or alert a health care provider or others of the abnormality, either directly through an alarm incorporated in the first module, or by transmission of an alarm to the second module. In a further embodiment, the first module may also be configured to communicate with various medical devices used to monitor a patient's condition, such as, for example, blood pressure monitors, ECG monitors, pulse oximetry monitors, temperature monitors, and the like. In some cases, the first module can be programmed to emit an alert to the patient or other persons if the monitored parameters fall outside a pre-determined range. In some embodiments, the first module can transmit a signal to a monitoring device to conduct an unscheduled measurement by the device. The first module may communicate with various health care providers at various locations, and in an embodiment may be able to notify the patient to whom it is assigned of an abnormality, and recommend corrective action through, for example an audible alert or recorded message.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 is a schematic representation of an exemplary Electronic Patient Monitoring system, showing paths of communication among system components.



FIG. 2 is an illustration of a display screen on a health care provider's portable communications device, showing a list of patients whose information the provider can access.



FIG. 3 is an illustration of a display screen on a health care provider's portable communications device, showing devices associated with a particular patient, with current data from the devices and one-touch access to some of the patient's medical information.



FIG. 4 is an illustration of a display screen on a health care provider's portable communications device, showing data entry fields for a prescription for a medication for use with an intravenous infusion pump.



FIG. 5 is an illustration of a display screen on a health care provider's portable communications device, showing a risk profile associated with an ordered medication, and a suggested course of action, as generated by the Monitoring.



FIG. 6 is an illustration of a display screen on a health care provider's portable communications device, showing a medication prescription ready for submission by the ordering provider.



FIG. 7 is an illustration of a display screen on a health care provider's portable communications device, showing how the Monitoring system can display confirmation to the ordering provider that the prescription has been transmitted to the pharmacist.





DETAILED DESCRIPTION

As shown in FIG. 1, components of the Electronic Patient Monitoring System may include one or more Monitoring Clients 1,4, each of which may be assigned and in physical proximity to an individual patient 2, and a more remote Monitoring Server 3 for the uploading of information from a number of Monitoring Clients 1,4, and for downloading information and instructions from various sources to the Monitoring Clients 1,4. When in the patient's room, a health care provider can interact directly with a Monitoring Client 1 to obtain information about the patient 2 or to enter orders pertaining to the patient 2. Alternatively, providers at remote locations (e.g., doctor's office, nursing station 5, hospital pharmacy 6) may interact with an individual Monitoring Client 1 through a communications link with the Monitoring Server 3, or directly via a hospital local area network having each Monitoring Client 1,4 as a node.


In an embodiment, each Monitoring Client 1 is assigned to a specific patient 2, and can be a desk-based, portable or hand-held controller with display and user input capability. Preferably, it is portable and allows for efficient data viewing and data entry, such as a notebook PC, netbook PC, tablet PC, or even a ‘smart-phone,’ with or without touch screen capability. The designation of a particular Monitoring Client 1 to a particular patient 2 may be made using any of a number of methods, including (but not limited to) a unique patient identifier using a bar coded or RFID tag-embedded wrist band, for example. The Monitoring Client 1 may include one or more microprocessors to send and receive information relevant to the patient's care or condition. In some embodiments, the Monitoring Client 1 may be physically associated with a medical infusion pump 7 either permanently or detachably. This can be accomplished by a docking interface between the two devices. The Monitoring Client 1 can communicate with the pump 7 in a number of ways, including, for example, through electrical contacts in the docking interface, by means of an electrical connector, or wirelessly by means of transceivers on each device. The Monitoring Client 1 can also communicate with other databases in the facility 8, with databases external to the facility 9,10, and with health care providers via portable communications devices 11 (including, for example, physicians, nurses, and pharmacists). This can be accomplished by a wired connection to a facility server through a connector in the patient's room (such as, for example, a Category 5 local area network connector), or wirelessly 12. In one embodiment, access to intra and extra facility databases is mediated 13 through the Monitoring Server 3, which can then centralize the software and application programming interfaces required to communicate with databases having disparate organization, formatting and communications protocols. Thus, in an embodiment, any software updates may be largely limited to the Monitoring Server 3, reducing the maintenance requirements on the individual Monitoring Clients 1,4. Optionally, a Monitoring Client 1 can communicate with medical treatment devices such as infusion pumps 7 to receive information about the progress of treatment, and to provide operational instructions to the treatment device. In another embodiment, the Monitoring Client 1 may also communicate with medical diagnostic or monitoring devices (such as, for example, an electrocardiographic (ECG) monitor 14, a blood pressure (BP) monitor 15, a pulse oximeter or CO2 capnometer 16, or other devices such as temperature monitors, etc.) to receive readout information from the devices, and potentially to instruct 18 the devices to take a reading when desired by a provider or by algorithm.


In an embodiment, the Monitoring Client 1 has the ability to communicate and interact directly with a health care provider using a hand-held or portable communications device 11. This may be conveniently accomplished wirelessly 12, so that communications can be maintained regardless of the patient's location in the facility, or the provider's location either within or outside the facility. In one aspect, information specific to the patient 2 can be stored locally in the Monitoring Client 1, so that the patient's health care provider can access the information directly without having to access the Monitoring Server 3. By incorporating appropriate safety and security clearances, changes to the settings or flow parameters of a connected infusion pump 7 or monitoring device 14-17 can be accomplished directly between a provider's communications device 11 and the Monitoring Client 1, with selected changes being also communicated to Monitoring Server 3, and thence to other appropriate locations, such as the Nursing Station 5, and/or Pharmacy 6. Furthermore, any new order pertaining to the patient 2 may be entered in the ordering provider's communications device 11 and transmitted to the Monitoring Client 1, which in turn can then notify the care giver (e.g. RN) via the care giver's own portable communications device 11. Preferably, any information acquired and stored in the Monitoring Client 1 is periodically uploaded to the Monitoring Server 3 and stored in a patient-specific database. Thus, if a patient's Monitoring Client 1 needs to be taken out of service, a new device can be assigned to the patient 2 and quickly re-populated with the patient's current information from the Monitoring Server 3. Orders, medications, progress notes, monitoring and treatment data from the patient's attached devices may also be uploaded from the Monitoring Client 1 to the patient's EHR 19, 19′ for permanent storage.


The Monitoring Server 3 may comprise a computer that can communicate with and provide some elements of control for a number of Monitoring Clients 4 in the facility. It may provide a Monitoring Clients 1, 4 with data extracted from a number of databases both within 8 and outside 9 of the facility. In an embodiment, the Monitoring Server 3 can interrogate the facility's EHR system 19 for targeted information pertaining to a patient 2, and then populate that patient's Monitoring Client 1 with a pre-defined set of information (such as, for example, the patient's age, height, weight, categories of diagnoses, current medications and medication categories, medication allergies and sensitivities, etc.). The Monitoring Server 3 may establish a link to EHR 19, Laboratory 20, Radiology 21, Pharmacy 22 and other systems (such as, e.g., Cardiology 23 or Scheduling database 24) in the facility when, for example, a Monitoring Client 1 has been assigned to a patient 2. With a unique patient identifier, the Monitoring Server 3 can obtain electronic access (permission) to receive and send patient-specific data from and to these systems. A pre-determined (but selectable) subset of the data may be downloadable into the Monitoring Client 1 memory. The information thus acquired can then serve as a key database against which new orders can be analyzed. Orders entered into a Monitoring Client 1 can be checked for compatibility with the patient-specific information obtained by the Monitoring Server 3. Optionally, for safety redundancy, orders entered remotely from a portable communications device 11 can be intercepted by the Monitoring Server 3 and similarly can be checked. The Monitoring Server 3 may also obtain information from medication databases residing in the facility's pharmacy 22 or externally 9 to determine whether a new patient order may generate an incompatibility with a patient's existing medications, for example. In an embodiment, the Monitoring Server 3 may be programmed to access publicly available internet sites 25 to determine whether new information pertaining to the patient's ordered medication should be downloaded and transmitted 13 in an alert to the patient's health care provider(s). The Monitoring Server 3 may also route information between remote portable communications devices 11 and a patient's Monitoring Client 1.


In an embodiment, the patient's physician, nurse or pharmacist may have access to the patient's Monitoring Client 1 to relay or receive new orders (such as medication orders, for example) pertaining to the patient 2. The Monitoring Client 1 or Server 3 may then log the new order and relay the request to the pharmacist 6, and the patient's nurse via the nurse's portable communications device 11 and/or via a fixed terminal at the nursing station 5. A ‘smart phone’ having a customized communications application with Monitoring Client 1 (such as, e.g., a Google Nexus One phone or Apple i-phone, among others) may serve as a convenient portable communications device 11 for providers who are not at a fixed location (such as at an office or remote nursing station). A tablet PC, netbook, or laptop computer may also serve as a convenient portable communications device 11 for both portable and fixed locations. A PC may act as a convenient communication device 11 for fixed or desktop locations. If a provider is located in the patient's room, he or she may enter or receive information pertaining to the patient 2 using a direct input through a keyboard or touch screen on the Monitoring Client 1.


Example of Monitoring-assisted Order Entry


The functionality of the Patient Monitoring system can be illustrated by an example in which an ordering provider enters a new medication prescription for a patient. In this scenario, the physician may view his list of admitted patients on his hand-held device after entering the appropriate security pass code. In this example, the physician's patients can be listed as shown in FIG. 2, with limited and user-selectable information 26 on each patient, such as, for example, age, diagnosis, and medical record number. Alert symbols 27 may be transmitted by the Monitoring Client 1 to the physician's device 11 if, for example, orders for the patient 2 are incomplete, the nurse has flagged the patient for attention, or if the Monitoring Client 1 has received input from a database or a patient monitoring device 14-17 that has exceeded a pre-determined threshold for physician notification.


After the physician selects a patient for further review, a display such as that shown in FIG. 3 may be transmitted to the physician's device 11. The physician can view user-selectable data originating from monitors 14-17 to which the patient is connected, and the physician may have one-touch access to a number of databases 19-21, 23 containing patient-specific information. In an embodiment, the Monitoring Client 1 may be connected or docked to an infusion pump 7 available for use with the patient 2. In a scenario illustrated in FIG. 3, the physician can press on the icon representing the infusion pump 7 to order an intravenous medication for the patient 2.



FIG. 4 shows one of a number of possible prescription ordering screens with which a physician can remotely order a medication. In the example illustrated, the physician enters the drug IV Nitroglycerin 28, which may be entered by typing or via a drop-down screen populated by the hospital pharmacy's formulary 22, accessed by the Monitoring Client 1 via the Monitoring Server 3. The ‘PDR’ button 29 may represent the physician's one-touch access to an in-hospital 22 or proprietary drug database 9 for detailed drug information. The physician can order the dose of medication, either directly or by accepting a default standard starting dose 30 provided by the Monitoring Client 1 via the Monitoring Server 3. The physician may also specify the maximum fluid infusion rate 31 for the infusion pump 7, in order to assist the pharmacist in preparing the proper concentration of the drug in a bag for infusion.



FIG. 5 shows an example of how the Patient Monitoring system can detect a risk of an adverse reaction after the physician has entered the prescription. The Monitoring Client 1 can compare the new medication 28 to the patient's existing medications and drug allergy list downloaded from the EHR 19. The Monitoring Server 3 preferably will have populated the appropriate patient-specific data into the Monitoring Client 1, and the Client 1 will be programmed to look up this information after the new medication order has been entered. The Monitoring Client 1 may be programmed to request a listing of significant adverse reactions and drug interactions associated with each of the patient's medications and the new medication 28 from the Monitoring Server 3. The Server 3, in turn can access a pharmacy database 22 or external database 9 for this information. If a potential drug interaction or adverse reaction common to an existing medication and the new medication 28 are detected, the Monitoring Client 1 may issue a warning 32 and transmit it to the ordering physician, as shown in FIG. 5. If the potential adverse reaction is due to an effect common to both the new medication and an existing medication, the Monitoring Client 1 may categorize this as a potentially additive adverse effect and issue a recommendation 33 to reduce the initial drug dose, for example, by 50%.


As shown in FIG. 6, the ordering physician has the option either to accept the recommendation 33 or edit the recommended dose to another value. In any event, the Monitoring Client 1 may generate and log a report 34 of the warning 32 and any corrective action 33, if any, taken by the physician, with the option for the physician to further edit the report before logging and entry into the patient's EHR 19.


Once the medication dosing is finally determined, the Monitoring Client 1 can forward the order to the communication devices of both the hospital pharmacist 6 and the patient's nurse 5. A report of the accomplishment of this task may then be transmitted back to the ordering physician 11, as shown in FIG. 7. The pharmacist can use the information provided by the ordering physician to mix an appropriate concentration of the medication in a solution bag. Both the medication vial and the solution bag may have identification tags, such as, e.g., bar code identifiers, that can be read into the pharmacist's communications device 6, and which can be verified as correct by the Monitoring Client 1 (using the pharmacy database 22 as accessed by the Monitoring Server 3). The pharmacist may then generate a unique identification label, such as a bar code label, to be permanently affixed to the medication bag, the code now being linked uniquely to the patient 2 for whom the medication 28 has been prepared. The identifying code on the label may be transmitted to the Monitoring Client 1 for later reconciliation when the nurse is about to administer the medication 28.


After the prepared medication 28 arrives to the patient's floor, the nurse can then prepare to administer it to the patient 2. In this exemplary scenario, the Monitoring Client 1 may include an input device such as a bar code reader, which the nurse can use to verify that the identifying code on the medication bag matches the identity of the patient 2 for whom it has been prescribed. If the identification matches the information entered into the Monitoring Client 1 by the pharmacist, the nurse may be cleared by the device 1 to hang the medication bag and initiate the infusion via the infusion pump 7. In an embodiment, the Monitoring Client 1 displays to the nurse the prescription, including the dose, the maximum fluid rate for the patient, the concentration of the drug in the bag, and the infusion rate for the pump (which can optionally be calculated by a processor in the Monitoring Client 1). With this information, the nurse has the ability to manually calculate and verify that the infusion rate set by the Monitoring Client 1 for the pump 7 is correct.


Network Connectivity among System Components and Devices


A Monitoring Client device 1 can receive, process, and transmit information about a specific patient 2 to which it has been assigned or designated. The Monitoring Client 1 can most conveniently be attachable or dockable to an infusion pump 7, bed, or other device to which the patient 2 may be connected. The Monitoring Client 1 can be a hand-held device about the size of a wireless phone or tablet-style netbook, for example. Conveniently, it may have a touch-screen interface for use by the patient's provider. It may also be capable of providing output to a larger stationary display screen in the patient's room or at a nursing station 5 or other convenient location, either through a wired or wireless connection. Each Monitoring Client 1 may communicate with a central Monitoring Server 3, through which it can access patient data from the facility's EHR database 19, Laboratory database 20, Radiology database 21, Pharmacy database 22, or other databases in various other facility departments. In some cases, the Monitoring Client 1 can upload information it receives from patient monitoring systems 15-17 or from provider inputs to the patient's EHR 19 via the Monitoring Server 3. Monitoring Clients 1,4 may also receive information from databases outside of the facility through a Monitoring Server 3 having an internet connection 25. Various external databases 9 may thus be accessible, including various drug information databases and alert networks dealing with adverse medication-related events. The Monitoring Server 3 could be arranged, for example, to manage various levels of external database information helpful in keeping the Monitoring Client 1 contents as up-to-date as possible. This can be accomplished, for example, by comparing safety and drug information related to the patient as it becomes available, and prioritizing for updates/downloads on a data transfer schedule. The Monitoring Clients 1,4 may also communicate either directly or through the Monitoring Server 3 with portable communications devices 11 used by health care providers such as nurses, physicians and pharmacists. In some cases, these devices can have wired connections to the Monitoring Server 3 (if used, for example, in fixed locations such as hospital pharmacies or nursing stations). In other cases, a portable communications device 11 may communicate with the Monitoring Server 3 through VPN-based internet connections using a computer and a wired or wireless (such as, e.g., Blutooth or WiFi 802.11) connection 13 with the device 11. Alternatively, a hand-held device 11 (such as a wireless smart-phone or tablet netbook) may communicate directly 12 with the facility's Monitoring Client 1 via a cellular telephone network.


The communications link between the Monitoring Clients 1,4 and the Monitoring Server 3 may exist via a Category-5 wired network if widely available in the facility, or via wireless transmission using one of a number of standards, linking all the patient-specific Monitoring Clients 1,4 with the central Monitoring Server 3. The server 3 may then serve as a relay for communications with other facility servers 8, with web-based servers 25, and with inside and outside portable communications devices 11 carried by medical care providers. A wireless network provides the additional functionality of being able to communicate with the Monitoring Server 3 no matter where in the facility the patient 2 may be.


One method of blanketing an entire facility with wireless coverage involves having the facility obtain a license for a private cell-phone network. It may obtain or lease one or more micro-cellular frequencies to provide for a local communications network throughout the facility. This arrangement can preserve communications when patients and their Monitoring Clients 1,4 are moved from one location to another within the facility, maintaining communications with a Monitoring Server 3, various in-hospital and out-of-hospital databases 8,25, and users at fixed stations 5,6 or with mobile smart-phone, laptop or tablet-type devices 11 either inside or outside the hospital. An advantage of this type of system is the level of security provided by a licensed cellular communications infrastructure. In addition, an active wireless system can monitor the intensity of use in an area and direct additional channel frequencies to that area as needed. However, the bandwidth capacity of the network may not allow for efficient transmission of large data files, such as those containing radiology images, for example.


Alternatively or additionally, a hospital may implement an internet or intranet based communications system, in which an 802.11 WiFi-type protocol is used for wireless communications between individual Monitoring Clients 1,4 and the main Monitoring Server 3. To ensure adequate signal reception throughout the facility, a broadband antenna may be mounted on the roof of the building to collect cell phone signals from local wireless phone companies. A fiber-optic or cable network may then distribute the signals throughout the facility. Alternatively, the Monitoring Server 3 may use the private cell-phone network mentioned above. Although this system may not be as secure as a micro-cell system, it may be capable of providing the data throughput to accommodate large files, such as, for example, radiology images stored in the Radiology database 21. Home or office-based users may be able to connect to the hospital server through VPN access using wired or fiber-optic cable, or a DSL phone line. Data encryption may be used to provide needed patient data security. In some applications it may be advantageous to implement an asymmetric bandwidth communications network in order to optimize infrastructure capabilities. An example of this would be using licensed cellular frequencies in the “upstream” direction from the Monitoring Client 1 to the Monitoring Server 3 and the unlicensed 802.11 WiFi frequencies in the “downstream” direction from the Monitoring Server 3 to the Monitoring Client 1. In this example the upstream bandwidth and data rate requirements are relatively small compared to the downstream requirements. In low priority upstream transmissions the Monitoring Client 1 may allow data to be sent over a more distributed and cost-efficient network, such as, for example, a ZigBee network.


Communications between various monitoring devices and the Monitoring Client 1 may be achieved in a cost effective manner using, for example, a ZigBee wireless mesh network. Exemplary monitoring devices include ECG monitors 14, blood pressure monitors 15, pulse oximeters/capnometers 16, thermometers, and weight scales, among others. A common characteristic of most of these devices is that they provide periodic readouts of a single or small number of parameters. An intra-hospital device communications system such as the wireless mesh network provides for low-power digital radio connectivity among devices, and may employ a widely available, license-free 2.4 GHz frequency band. High-level communications protocols may be employed to ensure data fidelity and security. It is highly scalable, allowing hundreds or thousands of devices to be used on a single self-forming, self-healing mesh network. Devices connected to the network may communicate with one another and serve as repeaters to transfer data efficiently. The advantages of this system are its relatively low cost, scalability and mobility for the patient being monitored. The wireless range for devices linked to the wireless mesh network can approach 70 meters from each node of the system inside a facility. A similar network may be used in providing a wireless link within the facility between portable communications devices 11 carried by health care providers and their assigned patients through the patients' Monitoring Clients 1,4.


In many cases, the information being transmitted to the Monitoring client 1 may include a single parameter value (such as, for example, blood pressure) and a time stamp. The Monitoring Client 1 can be programmed to determine whether the value is outside a predetermined range, record the value in the patient's EHR 19, and notify the appropriate care-giver via their communications device 11. Furthermore, the network may enable bidirectional communications, and may allow the Monitoring Client 1 to query 15 the monitoring device, instructing it 18 to take an unscheduled reading. This can be useful, for example, when an abnormal reading is received, and its authenticity needs to be verified. The Monitoring Client 1 may be programmed to request a repeat reading to verify the abnormal reading. In a further refinement, the Monitoring Client 1 may be programmed to interrupt or adjust the infusion pump 7 flow rate, depending on the value of the reading received from a monitoring device 14-17. For example, if the BP monitor 15 indicates a blood pressure below a pre-determined acceptable range, the Monitoring Client 1 may be programmed to instruct the infusion pump 7 to stop the infusion, and it can transmit an urgent notification 12 to the health care provider(s)' communications devices 11. In another embodiment, if the infusion pump 7 is capable of measuring the volume of fluid being delivered to the patient 2, a processor in the Monitoring Client 1 may track the cumulative volume delivered and estimate the amount of fluid remaining in the medication bag. (Alternatively, a processor in the Monitoring Client 1 or infusion pump 7 may calculate the volume delivered from the infusion rate and elapsed time of infusion). Once the estimated residual volume reaches a pre-determined amount, the Monitoring Client 1 may signal the infusion pump 7 to reduce its flow rate to keep the patient's IV access 35 from running dry. It may also send a notification to the nurse's communications device 11, recommending replenishment of the medication or solution.

Claims
  • 1. An electronic patient monitoring system comprising: an active wireless system including a micro-cellular network, the active wireless system including a monitor configured to detect intensity of use, the active wireless system configured to allocate channel frequencies in accordance with the detected intensity of use of an area by directing additional channel frequencies to the area;a monitoring-server computer configured to retrieve physiological data of a patient from a database computer;a tablet configured to operatively communicate with the monitoring-server computer to receive and locally store the physiological data of the patient received from the monitoring-server computer;an infusion pump configured to infuse the patient with a medication; anda smart phone in operative communication with the tablet, wherein the smart phone is configured to access the physiological data of the patient directly from the tablet without accessing the monitoring-server computer, wherein the monitoring-server computer, the tablet, and the smart phone are configured to communicate with each other over the micro-cellular network enabling the tablet to remain in communication with the monitoring-server computer while being mobile within a facility, wherein the smart phone is configured to display the physiological data of the patient and editable default values next to a treatment order of the medication with an option to send the treatment order to the infusion pump and an option to view a reference of detailed information including information about the medication, the smart phone is configured to instruct the infusion pump to treat the patient with the medication via the micro-cellular network when the smart phone receives user input to treat the patient and the infusion pump is configured to execute treatment of the patient upon receipt of instruction from the smart phone, the smart phone configured to display the reference when the smart phone receives user input to view the reference.
  • 2. The electronic patient monitoring system according to claim 1, wherein the smart phone communicates with the tablet using a wireless connection.
  • 3. The electronic patient monitoring system according to claim 1, wherein the smart phone is configured to communicate with the tablet while outside of the facility having an associated patient located therein.
  • 4. The electronic patient monitoring system according to claim 1, wherein the smart phone is configured to change at least one setting of the infusion pump based at least in part on data other than the physiological data of the patient and transmit the at least one setting to the tablet.
  • 5. The electronic patient monitoring system according to claim 4, wherein the system is configured to communicate the at least one setting to the monitoring-server computer.
  • 6. The electronic patient monitoring system according to claim 1, wherein the tablet is configured to store at least one of orders, medications, progress notes, and monitoring and treatment data from a device attached to a patient.
  • 7. The electronic patient monitoring system according to claim 6, wherein the tablet is configured to periodically upload at least one of orders, medications, progress notes, and the monitoring and treatment data from the device attached to the patient to the database computer for permanent storage therein.
  • 8. The electronic patient monitoring system according to claim 1, wherein the physiological data of the patient includes at least one of an age, a height, a weight, a current medication, a medication category, a medication allergy, and a medication sensitivity.
  • 9. The electronic patient monitoring system according to claim 1, wherein the tablet is configured for assignment to a patient.
  • 10. The electronic patient monitoring system according to claim 9, wherein the tablet is configured for assignment to the patient utilizing a unique patient identifier.
  • 11. The electronic patient monitoring system according to claim 10, wherein the unique patient identifier is embedded on a bar code.
  • 12. The electronic patient monitoring system according to claim 10, wherein the unique patient identifier is embedded within an RFID tag-embedded wrist band.
  • 13. The electronic patient monitoring system according to claim 1, wherein the tablet is physically associated with the infusion pump.
  • 14. The electronic patient monitoring system according to claim 1, further comprising a patient monitoring device configured to measure a physical characteristic of a patient, wherein the tablet receives the measure of the physical characteristic of the patient in real time.
  • 15. The electronic patient monitoring system according to claim 1, wherein the tablet is adapted to determine if a new order meets predetermined criteria based upon a subset of the physiological data of the patient.
  • 16. A system comprising: a tablet configured to locally store physiological data of a patient;a smart phone in operative communication with the tablet, wherein the smart phone is configured to access the physiological data of the patient directly from the tablet;an infusion pump configured to infuse the patient with a medication; andan active wireless network including a micro-cellular network, the active wireless network configured to provide communications between the tablet and the smart phone within a facility, the active wireless network including an intensity monitor configured to determine usage intensity of an area, the active wireless network allocating channel frequencies in accordance with the determined intensity by directing additional channel frequencies to the area;wherein the smart phone is configured to display the physiological data of the patient and editable default values next to a treatment order of the medication with an option to send the treatment order to the infusion pump and an option to view a physician's desk reference including detailed drug information, the smart phone is configured to instruct the infusion pump to treat the patient with the medication via the active wireless network when the smart phone receives user input to treat the patient and the infusion pump is configured to execute treatment of the patient upon receipt of instruction from the smart phone, the smart phone is configured to display the physician's desk reference when the smart phone receives user input to view the physician's desk reference.
  • 17. The system according to claim 16, wherein the tablet is configured to be in physical proximity to an assigned patient.
  • 18. The system according to claim 16, wherein the tablet is configured to retrieve and store the physiological data of the patient from a database computer over the micro-cellular network.
  • 19. The system according to claim 18, wherein the database computer is an electronic health records database computer.
  • 20. The system according to claim 18, wherein the smart phone is configured to access the physiological data of the patient without accessing the database computer.
  • 21. The system according to claim 16, wherein the active wireless network includes a WIFI type network and the smart phone is configured to be in wireless communication with the tablet over at least one of the WIFI type network and the micro-cellular network.
  • 22. The system according to claim 16, wherein the smart phone includes a touchscreen.
  • 23. The system according to claim 22, wherein the smart phone is configured to provide one-touch access to a patient's medical information.
  • 24. The system according to claim 16, wherein the tablet is physically associated with the infusion pump.
  • 25. The system according to claim 16, wherein the tablet is configured to review information about a progress of treatment.
  • 26. The system according to claim 16, wherein the smart phone is configured to communicate a change to a setting of the infusion pump directly to the tablet.
  • 27. The system according to claim 16, wherein the tablet is configured to receive state parameters.
  • 28. The system according to claim 27, wherein the tablet is configured to signal the infusion pump to at least one of halt infusion, alter the rate of infusion, and alert the health care provider when a state parameter of the state parameters is abnormal.
  • 29. The system according to claim 28, wherein the tablet is configured to communicate the alert to the smart phone.
  • 30. The system according to claim 16, wherein the smart phone is configured to show a risk profile associated with an ordered medication presented to assist a user with dosage, delivery or potential risks of the ordered medication.
  • 31. The system according to claim 16, wherein the smart phone is configured to show a risk profile associated with a suggested course of action as generated by the tablet presented to assist a user with dosage, delivery or potential risks of an ordered medication.
  • 32. The system according to claim 16, wherein the tablet is configured to access a database computer within the facility and access another database computer outside of the facility.
  • 33. The system according to claim 16, wherein the physiological data of the patient includes at least one of an age, a height, a weight, a current medication, a medication category, a medication allergy, and a medication sensitivity.
CROSS-REFERENCES

The present application is a Continuation Application of U.S. patent application Ser. No. 13/971,258, filed Aug. 20, 2013 and entitled Electronic Patient Monitoring System, which will be U.S. Pat. No. 10,872,685, issuing on Dec. 22, 2020, which is a Continuation Application of U.S. patent application Ser. No. 13/011,543 filed Jan. 21, 2011 and entitled Electronic patient Monitoring System, and was on Feb. 21, 2012, which claims the benefit of prior U.S. Provisional Application No. 61/297,544, filed Jan. 22, 2010 and entitled Electronic Order Intermediation System for a Medical Facility. Each of these applications is hereby incorporated by reference herein in its entirety.

US Referenced Citations (617)
Number Name Date Kind
3658445 Pulman Apr 1972 A
4470758 Pazemenas et al. Sep 1984 A
4696671 Epstein Sep 1987 A
4877034 Atkins Oct 1989 A
4939689 Davis Jul 1990 A
5041086 Koenig Aug 1991 A
5153827 Coutre et al. Oct 1992 A
5207642 Orkin May 1993 A
5317506 Coutre May 1994 A
D348101 Poli Jun 1994 S
5331549 Crawford, Jr. Jul 1994 A
5368562 Blomquist Nov 1994 A
5482446 Williamson Jan 1996 A
5485408 Blomquist Jan 1996 A
5527289 Foster Jun 1996 A
5537618 Boulton Jul 1996 A
5681285 Ford et al. Oct 1997 A
5713856 Eggers Feb 1998 A
5719761 Gatti Feb 1998 A
5781442 Engleson Jul 1998 A
5836910 Duffy Nov 1998 A
5937353 Fapojuwo Aug 1999 A
5941846 Duffy Aug 1999 A
5961487 Davis Oct 1999 A
6021392 Lester Feb 2000 A
6024539 Blomquist Feb 2000 A
6139495 De La Huerga Oct 2000 A
6255951 De La Huerga Jul 2001 B1
6267559 Mossman Jul 2001 B1
6269340 Ford et al. Jul 2001 B1
6308171 De La Huerga Oct 2001 B1
6314384 Goetz Nov 2001 B1
6315720 Williams Nov 2001 B1
6317719 Schrier Nov 2001 B1
6319200 Lai Nov 2001 B1
6327570 Stevens Dec 2001 B1
6346886 De La Huerga Feb 2002 B1
6348777 Brown Feb 2002 B1
6398727 Bui Jun 2002 B1
6408330 DeLaHuerga Jun 2002 B1
6421650 Goetz Jul 2002 B1
6427088 Bowman, IV Jul 2002 B1
6519569 White Feb 2003 B1
6554798 Mann Apr 2003 B1
6579242 Bui Jun 2003 B2
6668196 Villegas Dec 2003 B1
6671563 Engelson Dec 2003 B1
6694334 DuLong Feb 2004 B2
6745764 Hickle Jun 2004 B2
6775577 Crnkovich Aug 2004 B2
6776152 Gray et al. Aug 2004 B2
6790198 White Sep 2004 B1
6880034 Manke Apr 2005 B2
6976349 Baldwin Dec 2005 B2
6985870 Martucci Jan 2006 B2
6993402 Klass Jan 2006 B2
7039878 Auer May 2006 B2
7096072 Engleson Aug 2006 B2
7103419 Engleson Sep 2006 B2
7107106 Engleson Sep 2006 B2
7117041 Engleson Oct 2006 B2
7161484 Tsoukalis Jan 2007 B2
7165221 Monteleone Jan 2007 B2
7171277 Engleson Jan 2007 B2
7216802 De La Huerga May 2007 B1
7236936 White Jun 2007 B2
7300418 Zaleski Nov 2007 B2
7302266 Sill et al. Nov 2007 B1
7303549 Flaherty Dec 2007 B2
7379885 Zakim May 2008 B1
7384410 Eggers Jun 2008 B2
7433853 Brockway Oct 2008 B2
7452190 Bouton Nov 2008 B2
7471994 Ford Dec 2008 B2
7539593 Machacek May 2009 B2
7565301 Moubayed Jul 2009 B2
7569030 Lebel Aug 2009 B2
7590551 Auer Sep 2009 B2
7612679 Fackler Nov 2009 B1
7636718 Steen Dec 2009 B1
7645258 White Jan 2010 B2
7647237 Malave Jan 2010 B2
7664660 Korpman Feb 2010 B2
7678071 Lebel Mar 2010 B2
7685003 Hasan Mar 2010 B2
7689394 Furem Mar 2010 B2
7693730 Hasan Apr 2010 B2
7699806 Ware Apr 2010 B2
7703042 Brummel Apr 2010 B2
7707047 Hasan Apr 2010 B2
7715277 de la Huerga May 2010 B2
7743975 Miller Jun 2010 B2
7771385 Eggers Aug 2010 B2
7771386 Eggers Aug 2010 B2
7788369 McAllen Aug 2010 B2
7813879 Bush Oct 2010 B2
7815602 Mann Oct 2010 B2
7818184 Penny Oct 2010 B2
7819843 Mann Oct 2010 B2
7831446 Korpman Nov 2010 B2
7835927 Schlotterbeck Nov 2010 B2
7839266 Hoglund Nov 2010 B2
7850641 Lebel Dec 2010 B2
7859401 Falck Dec 2010 B2
7860583 Condurso Dec 2010 B2
7871394 Halbert Jan 2011 B2
7873489 Dolgos Jan 2011 B2
7886231 Hopermann Feb 2011 B2
7893876 Brown Feb 2011 B2
7896842 Palmroos Mar 2011 B2
7901394 Ireland Mar 2011 B2
7911353 Bedingfield Mar 2011 B2
D636779 Boush Apr 2011 S
D636780 Musleh Apr 2011 S
7933780 De La Huerga Apr 2011 B2
7935076 Estes May 2011 B2
7938796 Moubayed May 2011 B2
7941534 de la Huerga May 2011 B2
7942844 Moberg May 2011 B2
7946985 Mastrototaro May 2011 B2
7955289 O'Mahony Jun 2011 B2
7976508 Hoag Jul 2011 B2
7978564 De La Huerga Jul 2011 B2
8025634 Moubayed Sep 2011 B1
8032226 Miller Oct 2011 B2
8038593 Friedman Oct 2011 B2
8041542 Pearson Oct 2011 B2
8060381 Dyer Nov 2011 B2
8065161 Howard et al. Nov 2011 B2
8073710 Hasan Dec 2011 B2
8095390 Bluemler Jan 2012 B2
8099301 Keresman, III Jan 2012 B2
8126728 Dicks Feb 2012 B2
8126729 Dicks Feb 2012 B2
8131565 Dicks Mar 2012 B2
8131566 Dicks Mar 2012 B2
8134459 Smith Mar 2012 B2
8149131 Blomquist Apr 2012 B2
8152486 Fathallah Apr 2012 B2
8178040 Brauer May 2012 B2
8192394 Estes Jun 2012 B2
8214227 Patterson Jul 2012 B2
8214234 Hasan Jul 2012 B2
8217946 Halpern Jul 2012 B2
8219413 Martinez Jul 2012 B2
8219982 Harkanyi Jul 2012 B2
8222768 Cassidy Jul 2012 B2
8225015 Gao-Saari Jul 2012 B2
8229760 Hasan Jul 2012 B2
D665401 Rai Aug 2012 S
8235938 Eggers Aug 2012 B2
8239780 Manetta Aug 2012 B2
8244555 Masson Aug 2012 B2
8255585 Levin Aug 2012 B2
8260635 Hasan Sep 2012 B2
8271106 Wehba Sep 2012 B2
8273018 Fackler Sep 2012 B1
8275576 Furem Sep 2012 B2
8275633 Baker Sep 2012 B2
8291337 Gannin Oct 2012 B2
8306797 Furem Nov 2012 B2
8308680 Chawla Nov 2012 B1
8312877 Elaz Nov 2012 B2
8317752 Cozmi Nov 2012 B2
D672785 Rai Dec 2012 S
8340792 Condurso Dec 2012 B2
8352290 Bartz Jan 2013 B2
8359338 Butterfield Jan 2013 B2
8373557 Smith Feb 2013 B2
8380126 Ma et al. Feb 2013 B1
8380536 Howard Feb 2013 B2
8414523 Blomquist Apr 2013 B2
D682861 Rounding May 2013 S
8444595 Brukalo May 2013 B2
8451230 Celentano May 2013 B2
D694774 Schuller Dec 2013 S
D701526 Poston Mar 2014 S
D705242 Bohmfalk May 2014 S
D709905 Bohmfalk Jul 2014 S
D714339 Hendrickson Sep 2014 S
8938684 Guertler Jan 2015 B2
8954336 Blomquist Feb 2015 B2
D726752 Angelides Apr 2015 S
D728601 Angelides May 2015 S
D728779 Sabin et al. May 2015 S
D733724 Kim Jul 2015 S
D735319 Sabin et al. Jul 2015 S
D736370 Sabin et al. Aug 2015 S
9151646 Kamen et al. Oct 2015 B2
D745661 Collins et al. Dec 2015 S
D749206 Johnson et al. Feb 2016 S
D751689 Peret et al. Mar 2016 S
D751690 Peret et al. Mar 2016 S
D752209 Peret et al. Mar 2016 S
9295778 Kamen et al. Mar 2016 B2
D754065 Gray et al. Apr 2016 S
D756386 Kendler et al. May 2016 S
D758399 Kendler et al. Jun 2016 S
D760288 Kendler et al. Jun 2016 S
D760289 Kendler et al. Jun 2016 S
9364394 Demers et al. Jun 2016 B2
9372486 Peret et al. Jun 2016 B2
D760782 Kendler et al. Jul 2016 S
D760888 Gill et al. Jul 2016 S
9400873 Kamen et al. Jul 2016 B2
9408966 Kamen Aug 2016 B2
D767756 Sabin Sep 2016 S
9435455 Peret et al. Sep 2016 B2
D768716 Kendler et al. Oct 2016 S
9465919 Kamen et al. Oct 2016 B2
9488200 Kamen et al. Nov 2016 B2
D774645 Gill et al. Dec 2016 S
9518958 Wilt et al. Dec 2016 B2
9636455 Kamen et al. May 2017 B2
D789516 Gill et al. Jun 2017 S
9675756 Kamen et al. Jun 2017 B2
9677555 Kamen et al. Jun 2017 B2
9687417 Demers et al. Jun 2017 B2
D792963 Gill Jul 2017 S
D795424 Sloss Aug 2017 S
D795805 Gray et al. Aug 2017 S
9719964 Blumberg Aug 2017 B2
9724465 Peret et al. Aug 2017 B2
9724466 Peret et al. Aug 2017 B2
9724467 Peret et al. Aug 2017 B2
9730731 Langenfeld et al. Aug 2017 B2
9744300 Kamen et al. Aug 2017 B2
9746093 Peret et al. Aug 2017 B2
9746094 Peret et al. Aug 2017 B2
9759343 Peret et al. Sep 2017 B2
9759369 Gray et al. Sep 2017 B2
9772044 Peret et al. Sep 2017 B2
D799025 Johnson et al. Oct 2017 S
D801519 Sabin et al. Oct 2017 S
9789247 Kamen et al. Oct 2017 B2
D802118 Peret et al. Nov 2017 S
D803386 Sabin et al. Nov 2017 S
D803387 Bodwell et al. Nov 2017 S
D804017 Sabin Nov 2017 S
9808572 Kamen et al. Nov 2017 B2
D805183 Sabin et al. Dec 2017 S
9856990 Peret et al. Jan 2018 B2
D813376 Peret et al. Mar 2018 S
D814021 Sabin Mar 2018 S
D815730 Collins et al. Apr 2018 S
D816685 Kendler et al. May 2018 S
D816829 Peret et al. May 2018 S
D817479 Sabin et al. May 2018 S
D817480 Sabin et al. May 2018 S
9968730 Blumberg, Jr. et al. May 2018 B2
9976665 Peret et al. May 2018 B2
10044791 Kamen et al. Aug 2018 B2
10082241 Janway et al. Sep 2018 B2
10088346 Kane et al. Oct 2018 B2
10108785 Kamen et al. Oct 2018 B2
10113660 Peret et al. Oct 2018 B2
10126267 Blumberg, Jr. Nov 2018 B2
10185812 Kamen et al. Jan 2019 B2
10202970 Kamen et al. Feb 2019 B2
10202971 Kamen et al. Feb 2019 B2
10220135 Kamen et al. Mar 2019 B2
10228683 Peret et al. Mar 2019 B2
10242159 Kamen et al. Mar 2019 B2
10245374 Kamen et al. Apr 2019 B2
10265463 Biasi et al. Apr 2019 B2
10288057 Kamen et al. May 2019 B2
10316834 Kamen et al. Jun 2019 B2
D854145 Collins Jul 2019 S
10380321 Kamen et al. Aug 2019 B2
10391241 Desch et al. Aug 2019 B2
D860437 Collins Sep 2019 S
10426517 Langenfeld et al. Oct 2019 B2
10436342 Peret et al. Oct 2019 B2
10453157 Kamen et al. Oct 2019 B2
10468132 Kamen et al. Nov 2019 B2
10471402 Demers et al. Nov 2019 B2
10478261 Demers et al. Nov 2019 B2
10488848 Peret et al. Nov 2019 B2
10561787 Kamen et al. Feb 2020 B2
10563681 Kamen et al. Feb 2020 B2
10571070 Gray et al. Feb 2020 B2
10655779 Janway et al. May 2020 B2
10670182 Janway et al. Jun 2020 B2
10718445 Yoo Jul 2020 B2
10722645 Kamen et al. Jul 2020 B2
10739759 Peret et al. Aug 2020 B2
10753353 Kamen et al. Aug 2020 B2
10761061 Wilt et al. Sep 2020 B2
10839953 Kamen et al. Nov 2020 B2
10844970 Peret et al. Nov 2020 B2
D905848 Sloss et al. Dec 2020 S
10857293 Kamen et al. Dec 2020 B2
10872685 Blumberg, Jr. et al. Dec 2020 B2
10876868 Kane et al. Dec 2020 B2
10894638 Peret et al. Jan 2021 B2
10911515 Biasi et al. Feb 2021 B2
20010051787 Haller et al. Jan 2001 A
20010031944 Peterson Oct 2001 A1
20010044731 Coffman et al. Nov 2001 A1
20020013538 Teller Jan 2002 A1
20020016568 Lebel et al. Feb 2002 A1
20020032583 Joao Mar 2002 A1
20020044059 Reeder et al. Apr 2002 A1
20020072934 Ross et al. Jun 2002 A1
20020077852 Ford et al. Jun 2002 A1
20020084904 De La Huerga Jul 2002 A1
20020169636 Eggers et al. Nov 2002 A1
20020178126 Beck Nov 2002 A1
20020184589 Eatough Dec 2002 A1
20020188465 Gogolak Dec 2002 A1
20030036683 Kehr et al. Feb 2003 A1
20030036744 Struys et al. Feb 2003 A1
20030046110 Gogolak Mar 2003 A1
20030061073 Seow Mar 2003 A1
20030106553 Vanderveen Jun 2003 A1
20030114751 Pedain Jun 2003 A1
20030135087 Hickle et al. Jul 2003 A1
20030135388 Martucci Jul 2003 A1
20030140928 Bui et al. Jul 2003 A1
20030165128 Sisodia et al. Sep 2003 A1
20030167030 Weitzel et al. Sep 2003 A1
20040010425 Wilkes Jan 2004 A1
20040015132 Brown Jan 2004 A1
20040085186 Eveland et al. May 2004 A1
20040147818 Levy Jul 2004 A1
20040158193 Bui Aug 2004 A1
20040172283 Vanderveen Sep 2004 A1
20040193325 Bonderud Sep 2004 A1
20040193453 Butterfield Sep 2004 A1
20050021622 Cullen Jan 2005 A1
20050022184 Birkestrand Jan 2005 A1
20050055242 Bello Mar 2005 A1
20050060202 Taylor et al. Mar 2005 A1
20050070227 Shen et al. Mar 2005 A1
20050070767 Maschke Mar 2005 A1
20050086288 Data et al. Apr 2005 A1
20050099624 Staehr May 2005 A1
20050133027 Elaz et al. Jun 2005 A1
20050143632 Elaz et al. Jun 2005 A1
20050144043 Holland Jun 2005 A1
20050171815 Vanderveen Aug 2005 A1
20050177096 Bollish Aug 2005 A1
20050192844 Esler et al. Sep 2005 A1
20050224083 Crass Oct 2005 A1
20050288571 Perkins et al. Dec 2005 A1
20060047538 Condurso Mar 2006 A1
20060080140 Buttner Apr 2006 A1
20060089592 Kadhiresan et al. Apr 2006 A1
20060095300 Schrier May 2006 A1
20060149140 Eldridge Jul 2006 A1
20060149591 Hanf Jul 2006 A1
20060161214 Patel Jul 2006 A1
20060168043 Eisenberger et al. Jul 2006 A1
20060184123 Gillespie Aug 2006 A1
20060229557 Fathallah et al. Oct 2006 A1
20060253301 Simms et al. Nov 2006 A1
20060258985 Russell Nov 2006 A1
20060265246 Hoag Nov 2006 A1
20060294230 Takasu et al. Dec 2006 A1
20070061393 Moore Mar 2007 A1
20070078445 Malloy Apr 2007 A1
20070088574 Byer Apr 2007 A1
20070109325 Eveleigh May 2007 A1
20070136090 Loutzenhiser Jun 2007 A1
20070191817 Martin Aug 2007 A1
20070219823 Warner Sep 2007 A1
20070249286 Ma et al. Oct 2007 A1
20070250927 Naik Oct 2007 A1
20070255114 Ackermann et al. Nov 2007 A1
20070255250 Moberg et al. Nov 2007 A1
20070255348 Holtzclaw Nov 2007 A1
20080039744 Hamilton Feb 2008 A1
20080086086 Field et al. Apr 2008 A1
20080091175 Frikart Apr 2008 A1
20080097913 Dicks Apr 2008 A1
20080129496 Koblasz Jun 2008 A1
20080133265 Silkaitis Jun 2008 A1
20080140157 Goetz Jun 2008 A1
20080160492 Campbell et al. Jul 2008 A1
20080235765 Shimizu Sep 2008 A1
20080243055 Fathallah Oct 2008 A1
20080255438 Saidara Oct 2008 A1
20080262441 Walborn Oct 2008 A1
20080281259 Owens et al. Nov 2008 A1
20080300572 Rankers et al. Dec 2008 A1
20090006640 Lambertus et al. Jan 2009 A1
20090063187 Johnson et al. Mar 2009 A1
20090069642 Gao et al. Mar 2009 A1
20090069743 Krishnamoorthy Mar 2009 A1
20090099866 Newman Apr 2009 A1
20090099867 Newman Apr 2009 A1
20090275808 DiMaio et al. Apr 2009 A1
20090119330 Sampath et al. May 2009 A1
20090150818 Bakhreiba Jun 2009 A1
20090153058 Feng Jun 2009 A1
20090153463 Arrizza Jun 2009 A1
20090153595 Cozmi Jun 2009 A1
20090157432 Palmroos Jun 2009 A1
20090163855 Shin et al. Jun 2009 A1
20090183147 Davis Jul 2009 A1
20090184842 Baldus et al. Jul 2009 A1
20090203329 White Aug 2009 A1
20090210152 Kawa Aug 2009 A1
20090216562 Faulkner Aug 2009 A1
20090217194 Martin et al. Aug 2009 A1
20090234672 Dicks Sep 2009 A1
20090240526 Vesto Sep 2009 A1
20090270810 DeBelser et al. Oct 2009 A1
20090270833 DeBelser et al. Oct 2009 A1
20100019910 Hassing et al. Jan 2010 A1
20100145506 Waugh et al. Feb 2010 A1
20100094653 Tribble Apr 2010 A1
20100106224 Von Arx et al. Apr 2010 A1
20100114027 Jacobson May 2010 A1
20100130933 Holland May 2010 A1
20100292544 Sherman et al. May 2010 A1
20100150176 Yakashiro Jun 2010 A1
20100160628 Peglion et al. Jun 2010 A1
20100176166 Siagri et al. Jul 2010 A1
20100229096 Maiocco Sep 2010 A1
20100234718 Sampath Sep 2010 A1
20100257189 Campbell Oct 2010 A1
20100268157 Wehba Oct 2010 A1
20100280486 Khair Nov 2010 A1
20100287006 Cannon Nov 2010 A1
20100292556 Golden Nov 2010 A1
20100298662 Yu Nov 2010 A1
20110004186 Butterfield Jan 2011 A1
20110006876 Moberg et al. Jan 2011 A1
20110071420 St. Pierre et al. Mar 2011 A1
20110074342 MacLaughlin Mar 2011 A1
20110105979 Schlaeper May 2011 A1
20110112418 Feild et al. May 2011 A1
20110119612 Gannon May 2011 A1
20110152629 Eaton et al. Jun 2011 A1
20110153343 Tremblay Jun 2011 A1
20110167250 Dicks Jul 2011 A1
20110173704 Hanov Jul 2011 A1
20110179083 Galloway et al. Jul 2011 A1
20110179405 Dicks Jul 2011 A1
20110184379 Van Antwerp Jul 2011 A1
20110191767 Pinsky et al. Aug 2011 A1
20110196306 De La Huerga Aug 2011 A1
20110205965 Sprigg et al. Aug 2011 A1
20110218406 Hussain Sep 2011 A1
20110224646 Yodfat Sep 2011 A1
20110231203 Rosow Sep 2011 A1
20110231204 De La Huerga Sep 2011 A1
20110241878 Hoag Oct 2011 A1
20110276605 Masson Nov 2011 A1
20110282168 Weiss Nov 2011 A1
20110282688 Raggousis Nov 2011 A1
20110282691 Coffman Nov 2011 A1
20110313789 Kamen et al. Dec 2011 A1
20110320049 Chossat Dec 2011 A1
20120011253 Friedman Jan 2012 A1
20120016215 Condurso Jan 2012 A1
20120016295 Tsoukalis Jan 2012 A1
20120016305 Jollota et al. Jan 2012 A1
20120029300 Paquet Feb 2012 A1
20120029307 Paquet Feb 2012 A1
20120029308 Paquet Feb 2012 A1
20120029309 Paquet Feb 2012 A1
20120029310 Paquet Feb 2012 A1
20120029311 Raptis Feb 2012 A1
20120029312 Beaudry Feb 2012 A1
20120029314 Paquet Feb 2012 A1
20120029315 Raptis Feb 2012 A1
20120029316 Raptis Feb 2012 A1
20120029941 Malave Feb 2012 A1
20120030547 Raptis Feb 2012 A1
20120047289 Krzystofczyk et al. Feb 2012 A1
20120053533 Butterfield Mar 2012 A1
20120062387 Vik Mar 2012 A1
20120065990 Howard Mar 2012 A1
20120066609 Howard Mar 2012 A1
20120075061 Barnes Mar 2012 A1
20120078218 Barnes Mar 2012 A1
20120084303 Ledford Apr 2012 A1
20120092157 Tran Apr 2012 A1
20120116796 Bellon May 2012 A1
20120116800 McCallie May 2012 A1
20120123229 Butterfield May 2012 A1
20120124174 Nudelman May 2012 A1
20120130308 Silkaitis May 2012 A1
20120157920 Flachbart Jun 2012 A1
20120172802 Blomquist Jul 2012 A1
20120176394 Vik Jul 2012 A1
20120179093 Rinehart Jul 2012 A1
20120179136 Rinehart Jul 2012 A1
20120185267 Kamen Jul 2012 A1
20120239824 Nguyen Sep 2012 A1
20120260012 Gao-Saari Oct 2012 A1
20120302991 Blomquist Nov 2012 A1
20120303388 Venkata et al. Nov 2012 A1
20120310205 Lee Dec 2012 A1
20120323212 Murphy Dec 2012 A1
20130006651 Saus Jan 2013 A1
20130006666 Schneider Jan 2013 A1
20130012880 Blomquist Jan 2013 A1
20130030830 Schmoll Jan 2013 A1
20130041257 Nemoto Feb 2013 A1
20130042194 Gannon Feb 2013 A1
20130045764 Vik Feb 2013 A1
20130046871 Vik Feb 2013 A1
20130091191 Levin Apr 2013 A1
20130104120 Arrizza Apr 2013 A1
20130132465 Brown May 2013 A1
20130133036 Wang May 2013 A1
20130141329 Halbert Jun 2013 A1
20130177455 Kamen Jul 2013 A1
20130182381 Gray Jul 2013 A1
20130184676 Kamen Jul 2013 A1
20130188040 Kamen Jul 2013 A1
20130191513 Kamen Jul 2013 A1
20130197693 Kamen Aug 2013 A1
20130204188 Kamen Aug 2013 A1
20130227462 Hsu Aug 2013 A1
20130272773 Kamen Oct 2013 A1
20130281965 Kamen Oct 2013 A1
20130297330 Kamen Nov 2013 A1
20130310990 Peret et al. Nov 2013 A1
20130317753 Kamen Nov 2013 A1
20130317837 Ballantyne Nov 2013 A1
20130336814 Kamen Dec 2013 A1
20130339049 Blumberg, Jr. Dec 2013 A1
20130346108 Kamen Dec 2013 A1
20140165703 Wilt Jun 2014 A1
20140180711 Kamen Jun 2014 A1
20140188076 Kamen Jul 2014 A1
20140188516 Kamen Jul 2014 A1
20140195639 Kamen Jul 2014 A1
20140227021 Kamen Aug 2014 A1
20140278458 Borges et al. Sep 2014 A1
20140318639 Peret Oct 2014 A1
20140343492 Kamen Nov 2014 A1
20150002667 Peret et al. Jan 2015 A1
20150002668 Peret et al. Jan 2015 A1
20150002677 Peret et al. Jan 2015 A1
20150033823 Blumberg, Jr. Feb 2015 A1
20150154364 Biasi et al. Jun 2015 A1
20150157791 Desch et al. Jun 2015 A1
20150238228 Langenfeld et al. Aug 2015 A1
20150257974 Demers et al. Sep 2015 A1
20150314083 Blumberg, Jr. et al. Nov 2015 A1
20150332009 Kane et al. Nov 2015 A1
20160055397 Peret et al. Feb 2016 A1
20160055649 Peret et al. Feb 2016 A1
20160061641 Peret et al. Mar 2016 A1
20160063353 Peret et al. Mar 2016 A1
20160073063 Peret et al. Mar 2016 A1
20160084434 Janway et al. Mar 2016 A1
20160097382 Kamen et al. Apr 2016 A1
20160131272 Yoo May 2016 A1
20160158437 Biasi et al. Jun 2016 A1
20160179086 Peret et al. Jun 2016 A1
20160184510 Kamen et al. Jun 2016 A1
20160203292 Kamen et al. Jul 2016 A1
20160262977 Demers et al. Sep 2016 A1
20160319850 Kamen et al. Nov 2016 A1
20160346056 Demers et al. Dec 2016 A1
20160362234 Peret et al. Dec 2016 A1
20170011202 Kamen et al. Jan 2017 A1
20170045478 Wilt et al. Feb 2017 A1
20170216516 Dale et al. Aug 2017 A1
20170224909 Kamen et al. Aug 2017 A1
20170259230 Demers et al. Sep 2017 A1
20170266378 Kamen et al. Sep 2017 A1
20170268497 Kamen et al. Sep 2017 A1
20170284968 Blumberg, Jr. Oct 2017 A1
20170296745 Kamen et al. Oct 2017 A1
20170303969 Langenfeld et al. Oct 2017 A1
20170321841 Gray et al. Nov 2017 A1
20170333623 Kamen et al. Nov 2017 A1
20170335988 Peret et al. Nov 2017 A1
20180038501 Peret et al. Feb 2018 A1
20180066648 Kamen et al. Mar 2018 A1
20180080605 Janway et al. Mar 2018 A1
20180106246 Kamen et al. Apr 2018 A1
20180128259 Kamen et al. May 2018 A1
20180224012 Peret et al. Aug 2018 A1
20180228964 Blumberg, Jr. et al. Aug 2018 A1
20180252359 Janway et al. Sep 2018 A1
20180278676 Kamen et al. Sep 2018 A1
20190009018 Kamen et al. Jan 2019 A1
20190033104 Kane et al. Jan 2019 A1
20190041362 Blumberg, Jr. Feb 2019 A1
20190049029 Peret et al. Feb 2019 A1
20190134298 Kamen et al. May 2019 A1
20190139640 Kamen et al. May 2019 A1
20190154026 Kamen et al. May 2019 A1
20190170134 Kamen et al. Jun 2019 A1
20190175821 Kamen et al. Jun 2019 A1
20190179289 Peret et al. Jun 2019 A1
20190189272 Kamen et al. Jun 2019 A1
20190219047 Kamen et al. Jul 2019 A1
20190249657 Kamen et al. Aug 2019 A1
20190298913 Biasi et al. Oct 2019 A1
20190316948 Karol et al. Oct 2019 A1
20190328964 Desch et al. Oct 2019 A1
20190341146 Kamen et al. Nov 2019 A1
20190365421 Langenfeld et al. Dec 2019 A1
20200025305 Peret et al. Jan 2020 A1
20200051190 Kamen et al. Feb 2020 A1
20200054823 Baier et al. Feb 2020 A1
20200066388 Kamen et al. Feb 2020 A1
20200070113 Demers et al. Mar 2020 A1
20200078127 Demers et al. Mar 2020 A1
20200171241 Kamen et al. Jun 2020 A1
20200173469 Kamen et al. Jun 2020 A1
20200182400 Gray et al. Jun 2020 A1
20200278078 Janway et al. Sep 2020 A1
20200347949 Yoo Nov 2020 A1
20200371497 Peret et al. Nov 2020 A1
20200386220 Kamen et al. Dec 2020 A1
20200393414 Wilt et al. Dec 2020 A1
20210023296 Langenfeld et al. Jan 2021 A1
Foreign Referenced Citations (132)
Number Date Country
659233 May 1995 AU
738474 Sep 2001 AU
2003265858 Dec 2008 AU
2003256732 Jul 2009 AU
1386478 Dec 2002 CN
1472681 Feb 2004 CN
1610516 Apr 2005 CN
2722826 Sep 2005 CN
1829956 Sep 2006 CN
2868184 Feb 2007 CN
1936974 Mar 2007 CN
101166321 Apr 2008 CN
101258761 Sep 2008 CN
101584178 Nov 2009 CN
101821743 Sep 2010 CN
101907630 Dec 2010 CN
102046222 May 2011 CN
102122364 Jul 2011 CN
202168825 Mar 2012 CN
102637291 Aug 2012 CN
473240 Jun 1994 EP
477551 Jan 1995 EP
666699 Aug 1995 EP
319268 Jan 1997 EP
960627 Dec 1999 EP
612004 Oct 2000 EP
760244 May 2003 EP
1640028 Mar 2006 EP
1722310 Nov 2006 EP
1744262 Jan 2007 EP
1944709 Jul 2008 EP
2278511 Jan 2011 EP
2302884 Mar 2011 EP
2330524 Jun 2011 EP
2216913 Nov 2011 EP
649316 Aug 2013 EP
2020735 Nov 1979 GB
04126159 Nov 1990 JP
2002169891 Nov 2000 JP
2002177225 Dec 2000 JP
2002085556 Jul 2001 JP
2003277155 Mar 2002 JP
2004523305 Aug 2004 JP
2007143834 Nov 2005 JP
2007330424 Jun 2006 JP
2008301110 May 2007 JP
4814868 Dec 2007 JP
2009152999 Dec 2007 JP
2009192420 Feb 2008 JP
2010160628 Jan 2009 JP
2009152999 Jul 2009 JP
2009192420 Jul 2009 JP
2010160628 Jul 2010 JP
2012181795 Mar 2011 JP
2011124354 Jun 2011 JP
2013038501 Aug 2011 JP
4814868 Nov 2011 JP
2012187411 May 2012 JP
6180089 Aug 2012 JP
2012181795 Sep 2012 JP
2012187411 Oct 2012 JP
2013038501 Feb 2013 JP
6180089 Aug 2017 JP
WO9304285 Mar 1993 WO
WO9310835 Jun 1993 WO
WO9321978 Nov 1993 WO
WO9814234 Apr 1998 WO
WO9910829 Mar 1999 WO
WO9952575 Oct 1999 WO
WO0003344 Jan 2000 WO
WO0072181 Nov 2000 WO
WO0198876 Dec 2001 WO
WO02068018 Sep 2002 WO
WO02100262 Dec 2002 WO
WO03094091 Nov 2003 WO
WO03105931 Dec 2003 WO
WO2004012043 Feb 2004 WO
WO2004029853 Apr 2004 WO
WO2004054429 Jul 2004 WO
WO2004056301 Jul 2004 WO
WO2004066834 Aug 2004 WO
WO2004070546 Aug 2004 WO
WO2004070548 Aug 2004 WO
WO2004072828 Aug 2004 WO
WO2004087241 Oct 2004 WO
WO2005065750 Jul 2005 WO
WO2005083619 Sep 2005 WO
WO2005089263 Sep 2005 WO
WO2006015330 Feb 2006 WO
WO2006060291 Jun 2006 WO
WO2006086723 Aug 2006 WO
WO2006086735 Aug 2006 WO
WO2006121510 Nov 2006 WO
WO2006126105 Nov 2006 WO
WO2007126948 Mar 2007 WO
WO2007113709 Oct 2007 WO
WO2008022880 Feb 2008 WO
WO2008031821 Mar 2008 WO
WO2008097316 Aug 2008 WO
WO2008103991 Aug 2008 WO
WO2009003196 Dec 2008 WO
WO2009069642 Jan 2009 WO
WO2009055635 Apr 2009 WO
WO2009069642 Jun 2009 WO
WO2009107011 Sep 2009 WO
WO2010045119 Apr 2010 WO
WO2010077851 Jul 2010 WO
WO2010085867 Aug 2010 WO
WO2010129720 Nov 2010 WO
WO2010132860 Nov 2010 WO
WO2010135518 Nov 2010 WO
WO2011021098 Feb 2011 WO
WO2011066556 Jun 2011 WO
WO2011091998 Aug 2011 WO
WO2011109500 Sep 2011 WO
WO2011119810 Sep 2011 WO
WO2013095459 Jun 2013 WO
WO2013095459 Jun 2013 WO
WO2013096713 Jun 2013 WO
WO2013096718 Jun 2013 WO
WO2013096722 Jun 2013 WO
WO2013096909 Jun 2013 WO
WO2013176770 Nov 2013 WO
WO2013177357 Nov 2013 WO
WO2014100557 Jun 2014 WO
WO2014100571 Jun 2014 WO
WO2014100658 Jun 2014 WO
WO2014100687 Jun 2014 WO
WO2014100736 Jun 2014 WO
WO2014100744 Jun 2014 WO
WO2014144557 Sep 2014 WO
WO2015017275 Feb 2015 WO
Non-Patent Literature Citations (119)
Entry
Chapter 4.3 of Java, Distributed Computing, by Jim Farley, O'Reilly & Associated, Copyright 2001, accessed at https://docstore.mik.ua/orelly/java-ent/dist/ch04_03.htm on Jun. 28, 2021.
Hiroshi Tsuda et al.; Inter-Cloud Data Security for Secure Cloud-Based Business Collaborations, FUJITSU Sci. Tech. J., vol. 48, No. 2, Apr. 2012, pp. 169-176, retrieved from https://www.fujitsu.com/global/documents/about/resources/publications/fstj/archives/vol48-2/paper10.pdf on Jun. 28, 2021.
Aronson, Medication errors resulting from the confusion of drug names, 2004, Expert Opinion on Drug Safety 3:3, pp. 167-172.
Body area network for wireless patient monitoring, IET Commun., 2008, 2, pp. 215-222, E. Monton, J .F. Hernandez, J.M. Blasco, T. Herve', J Micallef, I. Grech, A. Brincat and V. Traver (Year: 2008).
A Self-Managing Framework for Health Monitoring, Intel Technolog Journal, vol. 10, Issue 4, 2006, Amit Baxi, Nagaju Kodalapura (Year: 2006).
Trbovich, P. L et al. The impact of traditional and smart pump infusion technology on nurse medication administration performance in a simulated inpatient unit. BMJ Quality & Safety 19.5 (2010): 430-434. (Year: 2010).
Link, Richard E. MD, Sam B. Bhayani MD, and Louis R. Kavoussi MD. A prospective comparison of robotic and Laparoscopic Pyeloplasty. Annals of Surgery (2006), 243:486-491.
Greg, HOWTO: Port-Forwarding The NW Blog, Oct. 22, 2007 www.networkwebcams.eo.uk/blog.
U.S. Appl. No. 17/354,451, filed Jun. 22, 2021.
AAMI and FDA, Infusing Patients Safely: Priority Issues from the AAMI/FDA Infusion Device Summit, Symposium, Oct. 5-6, 2010, pp. 1-48, AAMI, Arlington, VA, USA.
Office Action and Formal Examination dated Aug. 24, 2015, received in Columbian application No. 15/168,128 (L52CO).
Office Action and Formal Examination dated Aug. 28, 2015, received in Columbian application No. 15/167,289 (K22CO).
Office Action and Formal Examination dated Sep. 2, 2015, received in Columbian application No. 15168109 (K50CO).
Bianco et al., Architecting Service-Oriented Systems, CMU/SEI-2011-TN-008, Aug. 2011, 46 pages, Software Engineer Institute, Carnegie Mellon University, Hanscom AFB, Massachusetts.
B. Braun, B. Braun SpaceStation MRI, Automated Infusion System, brochure, 1 pg., B. Braun Meslungen AG.
B. Braun, Dialog+: Dialog with the future, brochure, Oct. 2008, 1-14, Edition Oct. 2008, B. Braun Avitum AG.
B. Braun, Integrated Glucose Control, brochure, 1-11, B. Braun Melsungen AG.
B. Braun, Outlook ES Safety Infusion System, 2008, 16 pgs., B. Braun Medical, Inc.
B. Braun, Perfusor Space PCA and Accessories: Instructions for Use, manual, Nov. 2010, 1-46, B. Braun Melsungen AG.
B. Braun, Space System Technical Data, brochure, , 7 pgs., B. Braun Meslungen AG.
B. Braun, SpaceControl for Automated Glucose Control: Instructions for use, manual, Dec. 2010, 1-43, B. Braun Melsungen AG.
B. Braun, SpaceStation and SpaceCom: Instructions for Use, manual, 1-39, B. Braun Melsungen AG.
B. Braun, The Whole Hospital in the Palm of Your Hand, Automated Infusion Systems, brochure, 1-24, B. Braun Melsungen AG.
Butterfield, Alaris SE Pump, Monitoring and Detection of IV Line Occlusions, 2010, 4 pgs., CareFusion Corporation.
Carayon et al., Observing Nurse Interaction with Infusion Pump Technologies, Advances in Patient Safety: vol. 2—Observing Medication Administration, 349-364.
Cardinal Health, Alaris DS Docking Station: Technical Service Manual, manual, 2007, 1-31, Issue 2, Cardinal Health, Inc.
Cardinal Health, Alaris Gateway Workstation: Technical Service Manual, manual, 2008, 1-67, Issue 4, Cardinal Health, Inc.
Cardinal Health, Alaris GP Volumetric Pump: Technical Service Manual, manual, 2008, 1-84, Issue 3, Cardinal Health, Inc.
Care Everywhere, Gateway User Manual: V1.0.13 W/CQI 1.6: For use with the Sigma Spectrum Pump: Care Everywhere Document No. CE-100-003-IFU, manual, 1-55, CareEverywhere LLC, 9 Tech Circle, Natick, MA, USA.
Carefusion, Alaris SE Pump: Models 7100/7130 and 7200/7230, Rev2.X—User Manual, manual, Apr. 2011, pp. i-126, CareFusion Corporation, San Diego, CA, United States.
Carefusion, Alaris System Direction for Use—with Alaris PC unit, Model 8015, Dec. 2011, 1-360, CareFusion Corporation, San Diego, CA, United States.
Carefusion, Enhance your skills, methodology and safety performance: Guardrails CQI Reporter Software, 2010, 1-2.
Carefusion, Infusion Products, catalog, 2011, 1-16, CareFusion Corporation, San Diego, CA, United States.
Charter Kontron, Envoy: The Standard For Bedside Patient Monitoring, catalog, England.
Communication pursuant to Article 94(3) EPC dated May 27, 2015, from the European Patent Office for application 11 820 830.5 (I97EP), 1-4.
Communication of the Substantive Examination Result dated Oct. 29, 2015, from the Mexican Institute of Industrial Property for application MX/a/2014/014267 (K66MX), 1-3.
Corsaro et al., Quality of Service in Publish/Subscribe Middleware, Apr. 26, 2006, 1-22, SELEX-SI—Roma.
FDA, Medical Devices: SEDASYS Computer-Assisted Personalized Sedation System—P080009, Recently-Approved Devices, Mar. 24, 2013, 2 pgs., U.S. Food and Drug Administration.
Invitation To Respond to Written Opinion from the Intellectual Property Office of Singapore for Application 11201504872Y (K50SG), dated Mar. 2, 2016.
First Examination Report from The Intellectual Property Office of New Zealand for Application 626636 (I97NZ), dated Nov. 13, 2014, 2 pgs.
Food and Drug Administration, Envoy Patient Monitor—Device Modification: Special 510(k) for 12 Lead ECG/Resp. Module, Aug. 16, 2001, 1-12.
Further Examination Report from The Intellectual Property Office of New Zealand for Application 626636 (I97NZ), dated Sep. 24, 2015, 2 pgs.
Ge Fanuc, Controller Solutions: More Choices for Your Applications, GE Fanuc Controller Solutions catalog, 2004, 1-160, GE Fanuc Automation, Inc.
GE Medical Systems Information Technologies, 510(k) Summary, Aug. 28, 2009, 1-6.
Gieras, Innovative Infusion Pump Technologies, Engineering in Medicine & Biology Society, Jun. 15, 2010, pp. 1-53, IEEE Long Island Chapter.
Goldman et al., Advancing the Adoption of Medical Device “Plug-and-Play” Interoperability to Improve Patient Safety and Healthcare Efficiency, a white paper from the MD PnP Program, Sep. 2009, 1-3, , MD PnP Program.
Goldman et al., Medical Device “Plug-and-Play” Interoperability Program, 2012, MD PnP Program.
Goldman, ASTM final F-2761, Medical Devices and Medical Systems—Essential safety requirements for equipment comprising the patient-centric integrated clinical environment (ICE)—Part 1: General requirements and conceptual model, 2008, 1-34, ASTM.
Goldman, Gaps in the System: Medical Device Interoperability, NIST, Oct. 18, 2006, 1-46, MD PnP.
Hawk, III, The Role of Color Coding in Medication Error Reduction, Action of the AMA House of Delegates 2004 Annual Meeting: Report of the Council on Scientific Affairs, CSA Report 5-A-04, pp. 1-8.
Hewlett Packard, HP Viridia Model 24/26 Series Anesthesia / Standard: Quick Guide, manual, 1998, 1-29, Hewlett Packard.
Hoenich et al., Research & Technology: The Current Status and Future Directions of Hemodialysis Machine Technology, Hemodialysis Horizons, 38-44, AAMI.
Hofmann, Modeling Medical Devices for Plug-and-Play Interoperability, Master of Engineering thesis, Massachusetts Institute of Technology, Jun. 2007, pp. 1-187, Robert Matthew Hofmann, MMVII.
Infusion Nurses Society, Infusion Nursing Standards of Practice, Journal of Infusion Nursing, Jan./Feb. 2011, pp. S1-S110, vol. 34, No. IS, Infusion Nurses Society.
Infusion Nurses Society, Policies and Procedures for Infusion Nursing, 2011, 1-162, 4th edition, Infusion Nurses Society, Inc.
International Search Report & Written Opinion dated May 14, 2012, received in International patent application No. PCT/US2011/066588 (I97WO), 9 pgs.
International Search Report & Written Opinion dated Aug. 7, 2014, received in International patent application No. PCT/US2013/076851 (K22WO), 19 pgs.
International Search Report & Written Opinion dated Sep. 4, 2014, received in International patent application No. PCT/US2013/077258 (K50WO), 18 pgs.
International Search Report & Written Opinion dated Jul. 14, 2014, received in International patent application No. PCT/US2013/077135 (L52WO), 18 pgs.
International Preliminary Report on Patentability dated Jul. 3, 2014, received in International patent application PCT/US2011/066588 (I97WO), 6 pgs.
International Preliminary Report on Patentability dated Jul. 2, 2015, received in International patent application No. PCT/US2013/076851 (K22WO), 13 pgs.
International Preliminary Report on Patentability dated Jul. 2, 2015, received in International patent application No. PCT/US2013/077258 (K50WO), 13 pgs.
International Preliminary Report on Patentability dated Dec. 4, 2014, received in International patent application No. PCT/US2013/042350 (K66WO), 13 pgs.
International Preliminary Report on Patentability dated Jul. 2, 2015, received in International patent application No. PCT/US2013/077135 (L52WO), 13 pgs.
ISO/IEC, Information Technology—Open Systems Interconnection—Basic Reference Model: The Basic Model, Nov. 15, 1994, 1-59, Second edition (Corrected and reprinted Jun. 15, 1996), ISO/IEC, Geneva, Switzerland.
Israelski, The Symbiq (Next-Generation) IV Infusion Pump: A Feature-Filled “Intelligent” Pump Developed with and for the End-User, May 2007, 1-4, Hospira, Inc.
Invitation to Pay Additional Fees and, Where Applicable, Protest Fee dated May 6, 2014, received in International patent application No. PCT/US2013/077135 (L52WO), 6 pgs.
Jetley et al., Safety Requirements based Analysis of Infusion Pump Software, 1-4, US Food and Drug Administration, Silver Spring, MD, United States.
Joshi et al., OMG's Data Distribution Service Standard: The OMG Data Distribution Service (DDS) Standard specifies a mandatory API for data-centric publish-subscribe, Dr. Dobb's: The World of Software Development, Nov. 20, 2006, 1-9.
King et al., Prototyping Closed Loop Physiologic Control with the Medical Device Coordination Framework, 200X, 1-11.
Millard et al., XEP-0060: Publish-Subscribe, Jul. 12, 2010, 1-173, Version 1.13, XMPP Standards Foundation (XSF).
National Patient Safety Agency, Design for Patient Safety: A Guide to the Design of Electronic Infusion Devices, booklet, 2010, pp. 1-96, Edition 1, National Patient Safety Agency, London, USA.
Nemeth et al., Making Information Technology a Team Player in Safety: The Case of Infusion Devices, Advances in Patient Safety: Interface Design for Infusion Devices, pp. 319-330, vol. 1, Feb. 2005.
Notice for Reason for Rejection, dated Oct. 6, 2015, received in Japanese patent application National Publication No. 2014-548986 (I97JP), 5 pgs.
Pfiedler Enterprises, A Comprehensive Surgical Checklist: Using Technology to Help Optimize Preparedness, Patient Safety and Performance (A Continuing Education Self-Study Activity), 2011, pp. 1-20, Pfiedler Enterprises.
Prusch et al., IV Interoperability: Smart Pump and BCMA Integration, brochure, Oct. 5, 2010, 1-13, Lancaster General Health.
Rafferty, Proposal for Wireless Transmission of Non-invasive Respiratory Data to the Servo Module of an Opioid Infusion-Pump for Real-Time Patient Safety Feedback Control, Yale School of Medicine (Publication date unknown but assumed to be prior to the filing date.).
Search Report and Written Opinion from The Intellectual Property Office of Singapore for Application 11201403511Y (I97SG), dated Feb. 9, 2015, 22 pgs.
Sprunk et al., System Design for Simultaneous Data Acquisition from Patient Monitor and.
Talbot et al., Making Stretchable Electronics, Technology Review, Aug. 21, 2012, 1-2, Sep./Oct. 2012, MIT.
The 2008 Annual Premier Breakthroughs Conference: Innovation Through Supply Chain, Technology, and Clinical Sessions, Christine Depietto, Supply Synergy, vol. 3, No. 2, Aug. 2008.
Turisco et al., Beyond E-Health Records, CSC World, Winter 2010, 26-29, CSC World.
Turisco et al., Equipped for Efficiency: Improved Nursing Care Through Technology, Dec. 2008, 1-29, California Healthcare Foundation.
Vanderveen, Technology Focus: Using Data to Improve Smart Intravenous Infusion Pumps, Human Factors Horizons, 2010, pp. 57-63, Human Factors Horizons.
Definition—wifi as downloaded on Jul. 23, 2015, 1 pg.
Wikipedia, Publish-Subscribe Pattern, Jul. 31, 2013, 1-5.
Wikipedia, RSS definition, as downloaded on Jul. 21, 2015, p. 1-9.
Written Opinion from The Intellectual Property Office of Singapore for Application 11201403511Y (I97SG), dated Jun. 19, 2015, 11 pgs.
Written Opinion from The Intellectual Property Office of Singapore for Application 11201403511Y (I97SG), dated Oct. 13, 2015, 11 pgs.
Invitation to Pay Additional Fees and, Where Applicable, Protest Fee dated Sep. 26, 2013, received in International patent application No. PCT/US2013/042350 (K66WO), 7 pgs.
International Search Report & Written Opinion dated Nov. 7, 2013, received in International patent application No. PCT/US2013/042350 (K66WO), 18 pgs.
Gregorczyk, David, et al., “A Proof of Concept for Medical Device Integration Using Web Services,” 9th Annual International Multi-Conference on Systems, Signals and Devices, Mar. 20-23, 2012, 6pgs.
Mauro, Christina, et al., “Standardized Device Services—A Design Pattern for Services Oriented Integration of Medical Devices” Proceedings of the 43rd Hawaii International Conference on System Sciences , Jan. 5-8, 2010, 10 pgs.
Trinugroho, Yohanes Baptista Dafferianto, et al. “A SOA-Based eHealth Service Platform in Smart Home Enviroment” 13th International Conference on e-Health Networking, Applications and Services: Healthcom 2011 :Jun. 13-15, 2011, Columbia, Missouri, USA, 4 pgs.
Invitation to Pay Additional Fees and, Where Applicable, Protest Fee dated May 19, 2014, received in International patent application No. PCT/US2013/077258 (K50WO), 7 pgs.
Invitation to Pay Additional Fees and, Where Applicable, Protest Fee dated May 23, 2014, received in International patent application No. PCT/US2013/076851 (K22WO), 8 pgs.
Invitation To Respond to Written Opinion from the Intellectual Property Office of Singapore for Application 10201603585V (R93SG), dated Mar. 10, 2017.
U.S. Appl. No. 61/297,544, filed Jan. 22, 2010.
U.S. Appl. No. 13/011,543, filed Jan. 21, 2011, US20110313789A1.
U.S. Appl. No. 13/333,574, filed Dec. 21, 2011, US20120185267A1.
PCT/US11/66588, Dec. 21, 2011, WO2013095459A1.
U.S. Appl. No. 61/651,322, filed May 24, 2012.
U.S. Appl. No. 13/723,239, filed Dec. 21, 2012, US20130297330A1.
U.S. Appl. No. 13/723,242, filed Dec. 21, 2012, US20130317753A1.
U.S. Appl. No. 13/723,253, filed Dec. 21, 2012, US20130191513A1.
U.S. Appl. No. 13/836,497, filed Mar. 15, 2013, US20130346108A1.
PCT/US13/42350, May 23, 2013, WO/2013/177357A1.
U.S. Appl. No. 13/900,655, filed May 23, 2013, US20130317837A1.
U.S. Appl. No. 13/971,258, filed Aug. 20, 2013, US20130339049A1.
U.S. Appl. No. 14/137,421, filed Dec. 20, 2013, US20140180711A1.
PCT/US13/77258, Dec. 20, 2013, WO2014100736A1.
U.S. Appl. No. 14/136,234, filed Dec. 20, 2013, US20140188516A1.
PCT/US13/77135, Dec. 20, 2013, WO/2014/100687A1.
PCT/US13/76851, Dec. 20, 2013, WO2014100557A1.
U.S. Appl. No. 14/451,904, filed Aug. 5, 2014, US20140343492A1.
U.S. Appl. No. 14/616,079, filed Feb. 6, 2015, US20150154364A1.
U.S. Appl. No. 16/271,993, filed Feb. 11, 2019, US20190189272A1.
U.S. Appl. No. 16/513,867, filed Jul. 17, 2019, US20190341146A1.
U.S. Appl. No. 16/654,391, filed Oct. 16, 2019, US20200051190A1.
Related Publications (1)
Number Date Country
20210098102 A1 Apr 2021 US
Provisional Applications (1)
Number Date Country
61297544 Jan 2010 US
Continuations (2)
Number Date Country
Parent 13971258 Aug 2013 US
Child 17118801 US
Parent 13011543 Jan 2011 US
Child 13971258 US